It is certainly just my opinion, and is only based on the

New Post Public Reply Private Reply Replies (1) Message Board
CDiddy TMART #58391
470
It is certainly just my opinion, and is only based on the fact that trials are usually not stopped. However, it is my hope and prayer that Leronlimab is so effective that they do in fact stop the trial. But in order to be pragmatic, I do not base my investing decisions on hope.

This is why I always come back to HIV, cancer and others. If this was strictly a covid play the risk would be much higher.
1

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Mopar's Exciting Innovations at SEMA 2024 Event Preview

Updated Category News Views 254

Introducing Mopar's Evolution at SEMA 2024 AUBURN HILLS, Mich. – The pinnacle of the automotive world is gathering at SEMA 2024, and Mopar is set to unveil revolutionary advancements that will redefine the muscle car experience. With the muscle car legacy rooted deeply in performance, the upcoming event raises the question of just how high the boundaries can be pushed...

Continue Reading
Allied Properties REIT Declares September Distribution Announced

Updated Category News Views 182

Allied Properties REIT Announces September 2024 Distribution Allied Properties REIT (“Allied”) (TSX:AP.UN) has declared that its Trustees have approved a distribution of $0.15 per unit for September 2024. This results in an annualized rate of $1.80 per unit. The distribution will be payable on a designated date to all unitholders who are on record by the end of the...

Continue Reading
Resecurity Showcases Innovative Solutions at Global AI Summit 2024

Updated Category News Views 170

Resecurity to Showcase AI-Driven Cybersecurity at the Global AI Summit 2024 Resecurity, a leader in cybersecurity, will take part in the Global AI Summit (GAIN) 2024. The event brings together experts and innovators to examine how advances in artificial intelligence are reshaping real-world applications across industries—security included. Spotlight on AI-Powered Cyber...

Continue Reading
Savara Inc. Shareholders: Your Chance to Join the Legal Battle

Updated Category News Views 207

Understanding the Opportunity for Action Investors holding shares of Savara Inc. (NASDAQ: SVRA) may find an important opportunity to engage in a class action lawsuit. The law firm spearheading this effort, known for its focus on shareholder rights, is reaching out to those affected by possible misstatements made by the company. What Led to the Class Action Lawsuit? The...

Continue Reading
Arteris Recognized for Exceptional Innovation in Tech Industry

Updated Category News Views 129

Arteris Celebrates Triumph at the International Business Awards Arteris, Inc. (Nasdaq: AIP), a prominent name in the semiconductor industry, is making waves after winning a Gold Stevie Award for being the Most Innovative Tech Company of the Year. This accolade comes from the highly competitive 22nd Annual International Business Awards, where companies across the globe vie...

Continue Reading